CanSino Biologics Inc.（CASBF）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · CASBF · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$1.03B	$0.82B	$0.35B	$1.03B	$4.30B
Cost of Revenue	$0.35B	$0.24B	$1.22B	$1.22B	$1.30B
Gross Profit	$0.68B	$0.58B	($0.88B)	($0.19B)	$3.00B
Gross Margin %(computed)	66.07%	70.37%	-253.78%	-18.10%	69.85%
Operating Expenses
R&D Expenses	$0.00B	$0.42B	$0.64B	$0.78B	$0.88B
G&A Expenses	$0.00B	$0.19B	$0.29B	$0.28B	$0.23B
Total Operating Expenses	$0.80B	$0.98B	$1.16B	$1.18B	$1.20B
Operating Income	($0.11B)	($0.40B)	($2.04B)	($1.37B)	$1.94B
Operating Margin %(computed)	-10.96%	-48.90%	-589.60%	-132.75%	45.14%
Interest Income	$0.07B	$0.06B	$0.10B	$0.07B	$0.08B
Interest Expense	$0.06B	$0.06B	$0.06B	$0.04B	$0.02B
Income Before Tax	$0.02B	($0.38B)	($1.98B)	($1.18B)	$1.94B
Income Tax Expense	($0.01B)	$0.00B	($0.01B)	($0.22B)	$0.03B
Net Income	$0.03B	($0.38B)	($1.48B)	($0.91B)	$1.91B
Net Margin %(computed)	2.63%	-45.93%	-429.55%	-88.21%	44.52%
Per Share & EBITDA
EPS (Basic)	$0.11	$-1.53	$-6.01	$-3.69	$7.74
Wtd Avg Shares	0.25B	0.25B	0.25B	0.25B	0.25B
EBITDA	$0.06B	($0.11B)	($1.65B)	($1.32B)	$1.85B
EBITDA Margin %(computed)	5.91%	-13.32%	-476.76%	-127.91%	43.01%